Ai Su-cisplatin in the treatment of advanced breast cancer clinical observation of 30 cases of.docVIP

Ai Su-cisplatin in the treatment of advanced breast cancer clinical observation of 30 cases of.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Ai Su-cisplatin in the treatment of advanced breast cancer clinical observation of 30 cases of

 PAGE \* MERGEFORMAT 6 Ai Su-cisplatin in the treatment of advanced breast cancer clinical observation of 30 cases of [Abstract] Objective To observe the Cha Yi Su (docetaxel) and cisplatin chemotherapy for advanced breast cancer, the efficacy and toxicity. Methods 30 patients with pathologically diagnosed with breast cancer, TNM stage Ⅳ , application of AI Su-cisplatin chemotherapy response rate was 56.7%; the main adverse reaction was myelosuppression. Conclusion Ai Su-cisplatin chemotherapy for advanced breast cancer curative effect, the patient is well tolerated. [Keywords:] AI Su-cisplatin in advanced breast cancer Breast cancer is a common malignancy of women in the United States and Europe the incidence of cancer among the women in the first. Chinese corporations are relatively low breast cancer-prone areas, but the incidence is increasing year by year, of which occupies a large proportion of advanced breast cancer. Therefore, chemotherapy in breast cancer accounted for a pivotal position. Ai Su is a Taxol-type drugs, is a new generation of anti-microtubule drug, it has a unique anti-tumor activity of a broad spectrum anti-tumor, and the effect is significant, particularly marked effect on breast cancer [1]. Authors since June 2003 to December 2007 using AI Su-cisplatin in the treatment of advanced breast cancer 30 cases, efficacy is very good, the report is as follows. A clinical data 1.1 General Information Select 30 cases of hospitalized patients, both female, aged 24 to 83 years old, with a median 53.5 years of age. Cases were confirmed by pathological examination, clinical evaluation of the objective indicators are available, metastases confirmed by cytology expected survival ≥ 3 months, KPS score amp;quot;60 points. Newly diagnosed in 12 cases, re-treatment in 18 cases. Heart, liver, kidney and bone marrow function was normal. Clinical staging: TNM stage IV, in which post-operative recurrence and distant metastasis, 21 cases were found in 9 c

您可能关注的文档

文档评论(0)

jiupshaieuk12 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:6212135231000003

1亿VIP精品文档

相关文档